Announcements

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Survivorship and Quality of Life” Section, which are listed below.

1. “Limited Evidence for the Benefits of Exercise in Older Adults with Hematological Malignancies: A Systematic Review and Meta-Analysis”
by Mary Jarden, Sofie Tscherning Lindholm, Gudrun Kaldan, Charlotte Grønset, Rikke Faebo Larsen, Anders Thyge Steen Larsen, Mette Schaufuss Engedal, Marta Kramer Mikkelsen, Dorte Nielsen, Anders Vinther et al.
Cancers 2024, 16(17), 2962; https://doi.org/10.3390/cancers16172962
Available online: https://www.mdpi.com/2072-6694/16/17/2962

2. “Complex Relationships between Diagnostics and Survival in Chronic Lymphocytic Leukemia in Denmark, Finland, Norway, and Sweden”
by Kari Hemminki, Frantisek Zitricky, Asta Försti, Tuija Tapaninen, Akseli Hemminki, Gunnar Juliusson and Carsten Utoft Niemann
Cancers 2024, 16(18), 3229; https://doi.org/10.3390/cancers16183229
Available online: https://www.mdpi.com/2072-6694/16/18/3229

3. “The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma”
by Matteo Boltri, Fabio Traunero, Luca Ongaro, Francesca Migliozzi, Fabio Vianello, Oliviero Lenardon, Francesco Visalli, Lorenzo Buttazzi, Daniele Maruzzi, Carlo Trombetta et al.
Cancers 2024, 16(20), 3519; https://doi.org/10.3390/cancers16203519
Available online: https://www.mdpi.com/2072-6694/16/20/3519

4. “A Patient-Centered Conceptual Model of AYA Cancer Survivorship Care Informed by a Qualitative Interview Study”
by Marlaine S. Figueroa Gray, Lily Shapiro, Caitlin N. Dorsey, Sarah Randall, Mallory Casperson, Neetu Chawla, Brad Zebrack, Monica M. Fujii, Erin E. Hahn, Theresa H. M. Keegan et al.
Cancers 2024, 16(17), 3073; https://doi.org/10.3390/cancers16173073
Available online: https://www.mdpi.com/2072-6694/16/17/3073

5. “The Cancer Patient Empowerment Program: A Comprehensive Approach to Reducing Psychological Distress in Cancer Survivors, with Insights from a Mixed-Model Analysis, Including Implications for Breast Cancer Patients”
by Gabriela Ilie, Gregory Knapp, Ashley Davidson, Stephanie Snow, Hannah M. Dahn, Cody MacDonald, Markos Tsirigotis and Robert David Harold Rutledge
Cancers 2024, 16(19), 3373; https://doi.org/10.3390/cancers16193373
Available online: https://www.mdpi.com/2072-6694/16/19/3373

6. “Baseline Association between Healthy Eating Index-2015 and Health-Related Quality of Life in Breast Cancer Patients Enrolled in a Randomized Trial”
by Giuseppe Porciello, Sergio Coluccia, Sara Vitale, Elvira Palumbo, Assunta Luongo, Maria Grimaldi, Rosa Pica, Melania Prete, Ilaria Calabrese, Serena Cubisino et al.
Cancers 2024, 16(14), 2576; https://doi.org/10.3390/cancers16142576
Available online: https://doi.org/10.3390/cancers16142576

7. “Association between Cognitive Function and Physical Function, Frailty, and Quality of Life in Older Breast Cancer Survivors”
by Diane Von Ah, Carielle Joy Rio, Allie Carter, Susan M. Perkins, Erin Stevens, Ashley Rosko, Ashley Davenport, Mathew Kalady, Anne M. Noonan, Adele Crouch et al.
Cancers 2024, 16(15), 2718; https://doi.org/10.3390/cancers16152718
Available online: https://www.mdpi.com/2072-6694/16/15/2718

8. “Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy—The CONKO 021—ChemTox Trial”
by Tobias Bleumer, Janine Abel, Wolfgang Böhmerle, Sebastian Schröder, Soo Ann Yap, Nigel Dross Engelbert Schaeper, Thomas Hummel, Sebastian Stintzing, Lars Uwe Stephan and Uwe Pelzer
Cancers 2024, 16(14), 2495; https://doi.org/10.3390/cancers16142495
Available online: https://www.mdpi.com/2072-6694/16/14/2495

9. “Stratification of Homologous Recombination Deficiency-Negative High-Grade Ovarian Cancer by the Type of Peritoneal Spread into Two Groups with Distinct Survival Outcomes”
by Simon Schnaiter, Esther Schamschula, Juliane Laschtowiczka, Heidelinde Fiegl, Johannes Zschocke, Alain Zeimet, Katharina Wimmer and Daniel Reimer
Cancers 2024, 16(11), 2129; https://doi.org/10.3390/cancers16112129
Available online: https://www.mdpi.com/2072-6694/16/11/2129

10. “Impacts of Employment Status, Partnership, Cancer Type, and Surgical Treatment on Health-Related Quality of Life in Irradiated Head and Neck Cancer Survivors”
by Ching-Rong Lin, Tsung-Min Hung, Eric Yi-Liang Shen, Ann-Joy Cheng, Po-Hung Chang, Shiang-Fu Huang, Chung-Jan Kang, Tuan-Jen Fang, Li-Ang Lee, Chih-Hung Chang et al.
Cancers 2024, 16(19), 3366; https://doi.org/10.3390/cancers16193366
Available online: https://www.mdpi.com/2072-6694/16/19/3366

11. “Virtual Reality to Improve the Psychological and Physical Well-Being in Cancer Patients: An Umbrella Review”
by Lucie Bachelar, Aude Michel and Nathalie Blanc
Cancers 2024, 16(23), 3943; https://doi.org/10.3390/cancers16233943
Available online: https://www.mdpi.com/2072-6694/16/23/3943

12. “Association Between Physical Activity and Pancreatic Cancer Risk and Mortality: A Systematic Review and Meta-Analysis”
by Mylena D. Bos, Jelmer E. Oor, Lucas Goense, N. Helge Meyer, Maximilian Bockhorn, Frederik J. H. Hoogwater, Joost M. Klaase and Maarten W. Nijkamp
Cancers 2024, 16(21), 3594; https://doi.org/10.3390/cancers16213594
Available online: https://www.mdpi.com/2072-6694/16/21/3594

13. “Timing of Resection of Spinal Meningiomas and Its Influence on Quality of Life and Treatment”
by Michael Schwake, Wesam Said, Marco Gallus, Emanuele Maragno, Stephanie Schipmann, Dorothee Spille, Walter Stummer and Benjamin Brokinkel
Cancers 2024, 16(13), 2336; https://doi.org/10.3390/cancers16132336
Available online: https://www.mdpi.com/2072-6694/16/13/2336

14. “Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy”
by Stefania Moramarco, Luigi De Angelis, Laura Bernardini, Lorenza Marconi, Gaia Piunno, Simonetta Siciliano, Andrea Malizia, Ersilia Buonomo, Alessia Pesaresi, Angela Andreoli et al.
Cancers 2024, 16(17), 3080; https://doi.org/10.3390/cancers16173080
Available online: https://www.mdpi.com/2072-6694/16/17/3080

15. “Psychological Interventions for Insomnia in Patients with Cancer: A Scoping Review”
by Alyssa Alinda Gonzalez, Gladys Janice Jimenez-Torres, Aline Rozman de Moraes, Yimin Geng, Varsha Pawate, Rida Khan, Santhosshi Narayanan and Sriram Yennurajalingam
Cancers 2024, 16(22), 3850; https://doi.org/10.3390/cancers16223850
Available online: https://www.mdpi.com/2072-6694/16/22/3850

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Molecular Cancer Biology” Section, which are listed below.

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Methods and Technologies Development” Section, which are listed below.

1. “Ensemble Deep Learning-Based Image Classification for Breast Cancer Subtype and Invasiveness Diagnosis from Whole Slide Image Histopathology”
by Aadhi Aadhavan Balasubramanian, Salah Mohammed Awad Al-Heejawi, Akarsh Singh, Anne Breggia, Bilal Ahmad, Robert Christman, Stephen T. Ryan and Saeed Amal
Cancers 2024, 16(12), 2222; https://doi.org/10.3390/cancers16122222
Available online: https://www.mdpi.com/2072-6694/16/12/2222

2. “Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas”
by Francesco D’Alò, Silvia Bellesi, Elena Maiolo, Eleonora Alma, Flaminia Bellisario, Rosalia Malafronte, Marcello Viscovo, Fabrizia Campana and Stefan Hohaus
Cancers 2024, 16(12), 2243; https://doi.org/10.3390/cancers16122243
Available online: https://www.mdpi.com/2072-6694/16/12/2243

3. “Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review”
by Giuseppe Francesco Papalia, Paolo Brigato, Luisana Sisca, Girolamo Maltese, Eliodoro Faiella, Domiziana Santucci, Francesco Pantano, Bruno Vincenzi, Giuseppe Tonini, Rocco Papalia et al.
Cancers 2024, 16(15), 2700; https://doi.org/10.3390/cancers16152700
Available online: https://www.mdpi.com/2072-6694/16/15/2700

4. “Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme”
by Abdulkerim Duman, Xianfang Sun, Solly Thomas, James R. Powell and Emiliano Spezi
Cancers 2024, 16(19), 3351; https://doi.org/10.3390/cancers16193351
Available online: https://www.mdpi.com/2072-6694/16/19/3351

5. “Ex Vivo Fluorescence Confocal Microscopy for Intraoperative Examinations of Lung Tumors as Alternative to Frozen Sections—A Proof-of-Concept Study”
by Max Kamm, Felix Hildebrandt, Barbara Titze, Anna Janina Höink, Hagen Vorwerk, Karl-Dietrich Sievert, Jan Groetzner and Ulf Titze
Cancers 2024, 16(12), 2221; https://doi.org/10.3390/cancers16122221
Available online: https://www.mdpi.com/2072-6694/16/12/2221

6. “Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation”
by Alexandra Charalampopoulou, Amelia Barcellini, Andrea Peloso, Alessandro Vanoli, Stefania Cesari, Antonia Icaro Cornaglia, Margarita Bistika, Stefania Croce, Lorenzo Cobianchi, Giovanni Battista Ivaldi et al.
Cancers 2024, 16(14), 2582; https://doi.org/10.3390/cancers16142582
Available online: https://www.mdpi.com/2072-6694/16/14/2582

7. “Point of Care Liquid Biopsy for Cancer Treatment—Early Experience from a Community Center”
by Champica Nicholas, Andrea Beharry, Anna M. Bendzsak, Kassandra R. Bisson, Keith Dadson, Shaan Dudani, Marco Iafolla, Kashif Irshad, Kirstin Perdrizet, William Raskin et al.
Cancers 2024, 16(14), 2505; https://doi.org/10.3390/cancers16142505
Available online: https://www.mdpi.com/2072-6694/16/14/2505

8. “Combined Fluorescence-Guided Surgery with 5-Aminolevulinic Acid and Fluorescein in Glioblastoma: Technical Description and Report of 100 Cases”
by Alessandro Pesaresi, Pietro La Cava, Marta Bonada, Pietro Zeppa, Antonio Melcarne, Fabio Cofano, Pietro Fiaschi, Diego Garbossa and Andrea Bianconi
Cancers 2024, 16(16), 2771; https://doi.org/10.3390/cancers16162771
Available online: https://www.mdpi.com/2072-6694/16/16/2771

9. “Enhancing Lymphoma Diagnosis, Treatment, and Follow-Up Using 18F-FDG PET/CT Imaging: Contribution of Artificial Intelligence and Radiomics Analysis”
by Setareh Hasanabadi, Seyed Mahmud Reza Aghamiri, Ahmad Ali Abin, Hamid Abdollahi, Hossein Arabi and Habib Zaidi
Cancers 2024, 16(20), 3511; https://doi.org/10.3390/cancers16203511
Available online: https://www.mdpi.com/2072-6694/16/20/3511

10. “AI Applied to Volatile Organic Compound (VOC) Profiles from Exhaled Breath Air for Early Detection of Lung Cancer”
by Manuel Vinhas, Pedro M. Leitão, Bernardo S. Raimundo, Nuno Gil, Pedro D. Vaz and Fernando Luis-Ferreira
Cancers 2024, 16(12), 2200; https://doi.org/10.3390/cancers16122200
Available online: https://www.mdpi.com/2072-6694/16/12/2200

11. “Three-Dimension Epithelial Segmentation in Optical Coherence Tomography of the Oral Cavity Using Deep Learning”
by Chloe Hill, Jeanie Malone, Kelly Liu, Samson Pak-Yan Ng, Calum MacAulay, Catherine Poh and Pierre Lane
Cancers 2024, 16(11), 2144; https://doi.org/10.3390/cancers16112144
Available online: https://www.mdpi.com/2072-6694/16/11/2144

12. “The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer”
by Sebastian Curcean, Andra Curcean, Daniela Martin, Zsolt Fekete, Alexandru Irimie, Alina-Simona Muntean and Cosmin Caraiani
Cancers 2024, 16(17), 3111; https://doi.org/10.3390/cancers16173111
Available online: https://www.mdpi.com/2072-6694/16/17/3111

13. “Types of Breast Cancer Surgery and Breast Reconstruction”
by Anna Golara, Mateusz Kozłowski, Jerzy Lubikowski and Aneta Cymbaluk-Płoska
Cancers 2024, 16(18), 3212; https://doi.org/10.3390/cancers16183212
Available online: https://www.mdpi.com/2072-6694/16/18/3212

14. “AI Survival Prediction Modeling: The Importance of Considering Treatments and Changes in Health Status over Time”
by Nabil Adam and Robert Wieder
Cancers 2024, 16(20), 3527; https://doi.org/10.3390/cancers16203527
Available online: https://www.mdpi.com/2072-6694/16/20/3527

15. “The Role of Radiotherapy, Chemotherapy, and Targeted Therapies in Adult Intramedullary Spinal Cord Tumors”
by Ines Esparragosa Vazquez and François Ducray
Cancers 2024, 16(16), 2781; https://doi.org/10.3390/cancers16162781
Available online: https://www.mdpi.com/2072-6694/16/16/2781

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Informatics and Big Data” Section, which are listed below.

1. “Integrating Omics Data and AI for Cancer Diagnosis and Prognosis”
by Yousaku Ozaki, Phil Broughton, Hamed Abdollahi, Homayoun Valafar and Anna V. Blenda
Cancers 2024, 16(13), 2448; https://doi.org/10.3390/cancers16132448
Available online: https://www.mdpi.com/2072-6694/16/13/2448

2. “Learning from Imbalanced Data: Integration of Advanced Resampling Techniques and Machine Learning Models for Enhanced Cancer Diagnosis and Prognosis”
by Fatih Gurcan and Ahmet Soylu
Cancers 2024, 16(19), 3417; https://doi.org/10.3390/cancers16193417
Available online: https://www.mdpi.com/2072-6694/16/19/3417

3. “Predicting Biochemical Recurrence of Prostate Cancer Post-Prostatectomy Using Artificial Intelligence: A Systematic Review”
by Jianliang Liu, Haoyue Zhang, Dixon T. S. Woon, Marlon Perera and Nathan Lawrentschuk
Cancers 2024, 16(21), 3596; https://doi.org/10.3390/cancers16213596
Available online: https://www.mdpi.com/2072-6694/16/21/3596

4. “Comparison between Three Radiomics Models and Clinical Nomograms for Prediction of Lymph Node Involvement in PCa Patients Combining Clinical and Radiomic Features”
by Domiziana Santucci, Raffaele Ragone, Elva Vergantino, Federica Vaccarino, Francesco Esperto, Francesco Prata, Roberto Mario Scarpa, Rocco Papalia, Bruno Beomonte Zobel, Francesco Rosario Grasso et al.
Cancers 2024, 16(15), 2731; https://doi.org/10.3390/cancers16152731
Available online: https://www.mdpi.com/2072-6694/16/15/2731

5. “Lung Cancer and Air Quality in a Large Urban County in the United States”
by Hollis Hutchings, Qiong Zhang, Sue C. Grady, Jessica Cox, Andrew Popoff, Carl P. Wilson, Shangrui Zhu and Ikenna Okereke
Cancers 2024, 16(11), 2146; https://doi.org/10.3390/cancers16112146
Available online: https://www.mdpi.com/2072-6694/16/11/2146

6. “A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity”
by Menghan Wang, Yanqi Xie, Jinpeng Liu, Austin Li, Li Chen, Arnold Stromberg, Susanne M. Arnold, Chunming Liu and Chi Wang
Cancers 2024, 16(13), 2488; https://doi.org/10.3390/cancers16132488
Available online: https://www.mdpi.com/2072-6694/16/13/2488

7. “The Evolution of Artificial Intelligence in Medical Imaging: From Computer Science to Machine and Deep Learning”
by Michele Avanzo, Joseph Stancanello, Giovanni Pirrone, Annalisa Drigo and Alessandra Retico
Cancers 2024, 16(21), 3702; https://doi.org/10.3390/cancers16213702
Available online: https://www.mdpi.com/2072-6694/16/21/3702

8. “Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion”
by Navid Sobhani, Alberto D’Angelo, Matteo Pittacolo, Giuseppina Mondani and Daniele Generali
Cancers 2024, 16(17), 3089; https://doi.org/10.3390/cancers16173089
Available online: https://www.mdpi.com/2072-6694/16/17/3089

9. “Testing and Validation of a Custom Retrained Large Language Model for the Supportive Care of HN Patients with External Knowledge Base”
by Libing Zhu, Yi Rong, Lisa A. McGee, Jean-Claude M. Rwigema and Samir H. Patel
Cancers 2024, 16(13), 2311; https://doi.org/10.3390/cancers16132311
Available online: https://www.mdpi.com/2072-6694/16/13/2311

10. “Explainable Thyroid Cancer Diagnosis Through Two-Level Machine Learning Optimization with an Improved Naked Mole-Rat Algorithm”
by Wojciech Książek
Cancers 2024, 16(24), 4128; https://doi.org/10.3390/cancers16244128
Available online: https://www.mdpi.com/2072-6694/16/24/4128

11. “Synthetic Boosted Resampling Using Deep Generative Adversarial Networks: A Novel Approach to Improve Cancer Prediction from Imbalanced Datasets”
by Fatih Gurcan and Ahmet Soylu
Cancers 2024, 16(23), 4046; https://doi.org/10.3390/cancers16234046
Available online: https://www.mdpi.com/2072-6694/16/23/4046

12. “The Performance and Clinical Applicability of HER2 Digital Image Analysis in Breast Cancer: A Systematic Review”
by Gauhar Dunenova, Zhanna Kalmataeva, Dilyara Kaidarova, Nurlan Dauletbaev, Yuliya Semenova, Madina Mansurova, Andrej Grjibovski, Fatima Kassymbekova, Aidos Sarsembayev, Daniil Semenov et al.
Cancers 2024, 16(15), 2761; https://doi.org/10.3390/cancers16152761
Available online: https://www.mdpi.com/2072-6694/16/15/2761

13. “Pan-Cancer, Genome-Scale Metabolic Network Analysis of over 10,000 Patients Elucidates Relationship between Metabolism and Survival”
by Jesse Bucksot, Katherine Ritchie, Matthew Biancalana, John A. Cole and Daniel Cook
Cancers 2024, 16(13), 2302; https://doi.org/10.3390/cancers16132302
Available online: https://www.mdpi.com/2072-6694/16/13/2302

14. “Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer”
by Eleni Josephides, Roberta Dunn, Annie-Rose Henry, John Pilling, Karen Harrison-Phipps, Akshay Patel, Shahreen Ahmad, Michael Skwarski, James Spicer, Alexandros Georgiou et al.
Cancers 2024, 16(17), 3058; https://doi.org/10.3390/cancers16173058
Available online: https://www.mdpi.com/2072-6694/16/17/3058 

15. “Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations”
by Matteo Valerio, Alessandro Inno, Alberto Zambelli, Laura Cortesi, Domenica Lorusso, Valeria Viassolo, Matteo Verzè, Fabrizio Nicolis and Stefania Gori
Cancers 2024, 16(16), 2845; https://doi.org/10.3390/cancers16162845
Available online: https://www.mdpi.com/2072-6694/16/16/2845

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Immunology and Immunotherapy” Section, which are listed below:

1. “Dendritic Cells in Shaping Anti-Tumor T Cell Response”
by Luciano Mazzoccoli and Bei Liu
Cancers 2024, 16(12), 2211; https://doi.org/10.3390/cancers16122211
Available online: https://www.mdpi.com/2072-6694/16/12/2211

2. “Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma”
by Paola Tacchetti, Simona Barbato, Katia Mancuso, Elena Zamagni and Michele Cavo
Cancers 2024, 16(13), 2337; https://doi.org/10.3390/cancers16132337
Available online: https://www.mdpi.com/2072-6694/16/13/2337

3. “Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review”
by Chiara Pozzessere, Bianca Mazini, Patrick Omoumi, Mario Jreige, Leslie Noirez, Antonia Digklia, François Fasquelle, Christine Sempoux and Clarisse Dromain
Cancers 2024, 16(14), 2585; https://doi.org/10.3390/cancers16142585
Available online: https://www.mdpi.com/2072-6694/16/14/2585

4. “Strategies for Improving CAR T Cell Persistence in Solid Tumors”
by Megen C. Wittling, Anna C. Cole, Brianna Brammer, Kailey G. Diatikar, Nicole C. Schmitt and Chrystal M. Paulos
Cancers 2024, 16(16), 2858; https://doi.org/10.3390/cancers16162858
Available online: https://www.mdpi.com/2072-6694/16/16/2858

5. “Contemporary Approaches to Immunotherapy of Solid Tumors”
by Alla V. Kuznetsova, Xenia A. Glukhova, Olga P. Popova, Igor P. Beletsky and Alexey A. Ivanov
Cancers 2024, 16(12), 2270; https://doi.org/10.3390/cancers16122270
Available online: https://www.mdpi.com/2072-6694/16/12/2270

6. “Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions”
by Tulika Ranjan, Vivek Podder, Kim Margolin, Vamsidhar Velcheti, Arun Maharaj and Manmeet Singh Ahluwalia
Cancers 2024, 16(19), 3388; https://doi.org/10.3390/cancers16193388
Available online: https://www.mdpi.com/2072-6694/16/19/3388

7. “Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer”
by Kennady K. Bullock and Ann Richmond
Cancers 2024, 16(12), 2189; https://doi.org/10.3390/cancers16122189
Available online: https://www.mdpi.com/2072-6694/16/12/2189

8. “Present and Future of Immunotherapy for Triple-Negative Breast Cancer”
by Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers and Shyam Nyati
Cancers 2024, 16(19), 3250; https://doi.org/10.3390/cancers16193250
Available online: https://www.mdpi.com/2072-6694/16/19/3250

9. “Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy”
by Lauren Julia Brown, Julie Ahn, Bo Gao, Harriet Gee, Adnan Nagrial, Eric Hau and Inês Pires da Silva
Cancers 2024, 16(11), 2136; https://doi.org/10.3390/cancers16112136
Available online: https://www.mdpi.com/2072-6694/16/11/2136

10. “Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma”
by Aurora Fernández-Galván, Pedro Rodríguez-Jiménez, Beatriz González-Sixto, María Teresa Abalde-Pintos and Beatriz Butrón-Bris
Cancers 2024, 16(11), 2135; https://doi.org/10.3390/cancers16112135
Available online: https://www.mdpi.com/2072-6694/16/11/2135

11. “Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints”
by Huijie Liu, Ayse Ece Cali Daylan, Jihua Yang, Ankit Tanwar, Alain Borczuk, Dongwei Zhang, Vincent Chau, Shenduo Li, Xuan Ge, Balazs Halmos et al.
Cancers 2024, 16(16), 2805; https://doi.org/10.3390/cancers16162805
Available online: https://www.mdpi.com/2072-6694/16/16/2805

12. “Advancement and Challenges in Monitoring of CAR-T Cell Therapy: A Comprehensive Review of Parameters and Markers in Hematological Malignancies”
by Weronika Ploch, Karol Sadowski, Wioletta Olejarz and Grzegorz W. Basak
Cancers 2024, 16(19), 3339; https://doi.org/10.3390/cancers16193339
Available online: https://www.mdpi.com/2072-6694/16/19/3339

13. “Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma”
by Chenkai Mao, Maria Poimenidou and Brian T. Craig
Cancers 2024, 16(16), 2865; https://doi.org/10.3390/cancers16162865
Available online: https://www.mdpi.com/2072-6694/16/16/2865

14. “IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance”
by Suprataptha U. Reddy, Fatema Zohra Sadia, Ales Vancura and Ivana Vancurova
Cancers 2024, 16(15), 2676; https://doi.org/10.3390/cancers16152676
Available online: https://www.mdpi.com/2072-6694/16/15/2676

15. “Cutaneous Squamous Cell Carcinoma of the Head and Neck: Pathological Features and What They Mean for Prognosis and Treatment”
by Uma Ramesh, Elizabeth Chiang, Haleigh Stafford, Jane Buell, Frank Materia, Moran Amit and Dan Yaniv
Cancers 2024, 16(16), 2866; https://doi.org/10.3390/cancers16162866
Available online: https://www.mdpi.com/2072-6694/16/16/2866

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

March is designated as Colorectal Cancer Awareness Month, with various global activities that will highlight and increase the awareness of colorectal cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of colorectal cancer, as published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information regarding this field. The list of the relevant papers can be found below.

“Colorectal Cancer: Epidemiology, Risk Factors, and Prevention”
by Gholamreza Roshandel, Fatemeh Ghasemi-Kebria and Reza Malekzadeh
Cancers 2024, 16(8), 1530; https://doi.org/10.3390/cancers16081530
Available online: https://www.mdpi.com/2072-6694/16/8/1530

“Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment”
by William H. Gmeiner
Cancers 2024, 6(5), 1029; https://doi.org/10.3390/cancers16051029
Available online: https://www.mdpi.com/2072-6694/16/5/1029

“The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer Development”
by Rui Dai, Bridget N. Kelly, Amarachi Ike, David Berger, Andrew Chan, David A. Drew, David Ljungman, David Mutiibwa, Rocco Ricciardi, Gerald Tumusiime et al.
Cancers 2024, 16(3), 676; https://doi.org/10.3390/cancers16030676
Available online: https://www.mdpi.com/2072-6694/16/3/676

“Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine”
by Pankaj Ahluwalia, Kalyani Ballur, Tiffanie Leeman, Ashutosh Vashisht, Harmanpreet Singh, Nivin Omar, Ashis K. Mondal, Kumar Vaibhav, Babak Baban and Ravindra Kolhe
Cancers 2024, 16(3), 480; https://doi.org/10.3390/cancers16030480
Available online: https://www.mdpi.com/2072-6694/16/3/480

“The National Burden of Colorectal Cancer in the United States from 1990 to 2019”
by Saqr Alsakarneh, Fouad Jaber, Azizullah Beran, Mohammad Aldiabat, Yazan Abboud, Noor Hassan, Mohamed Abdallah, Thaer Abdelfattah, Laith Numan , Wendell Clarkston et al.
Cancers 2024, 16(1), 205; https://doi.org/10.3390/cancers16010205
Available online: https://www.mdpi.com/2072-6694/16/1/205

“Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer”
by Nadia Saoudi González, Javier Ros, Iosune Baraibar, Francesc Salvà, Marta Rodríguez-Castells, Adriana Alcaraz, Ariadna García, Josep Tabernero and Elena Élez
Cancers 2024, 16(2), 412; https://doi.org/10.3390/cancers16020412
Available online: https://www.mdpi.com/2072-6694/16/2/412

“Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer”
by Keila S. Espinoza and Ashley J. Snider
Cancers 2024, 16(4), 789; https://doi.org/10.3390/cancers16040789
Available online: https://www.mdpi.com/2072-6694/16/4/789

“Robotic versus Laparoscopic Liver Resections for Colorectal Metastases: A Systematic Review and Meta-Analysis”
by Kamil Safiejko, Michal Pedziwiatr, Michal Pruc, Radoslaw Tarkowski, Marcin Juchimiuk, Marian Domurat, Jacek Smereka, Khikmat Anvarov, Przemyslaw Sielicki, Krzysztof Kurek et al.
Cancers 2024, 16(8), 1596; https://doi.org/10.3390/cancers16081596
Available online: https://www.mdpi.com/2072-6694/16/8/1596

“Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer”
by Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J. Raftery and Gabriele Pecher
Cancers 2024, 16(2), 388; https://doi.org/10.3390/cancers16020388
Available online: https://www.mdpi.com/2072-6694/16/2/388

“Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept”
by Hanna Hong, Chase J. Wehrle, Mingyi Zhang, Sami Fares, Henry Stitzel, David Garib, Bassam Estfan, Suneel Kamath, Smitha Krishnamurthi, Wen Wee Ma et al.
Cancers 2024, 16(5), 927; https://doi.org/10.3390/cancers16050927
Available online: https://www.mdpi.com/2072-6694/16/5/927

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Clinical Research of Cancer” Section, which are listed below:

1. “The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions”
by Angela Rina, Debora Maffeo, Francesca Minnai, Martina Esposito, Maria Palmieri, Viola Bianca Serio, Diletta Rosati, Francesca Mari, Elisa Frullanti and Francesca Colombo
Cancers 2024, 16(16), 2882; https://doi.org/10.3390/cancers16162882
Available online: https://www.mdpi.com/2072-6694/16/16/2882

2. “An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia”
by Gulsum E. Pamuk and Lori A. Ehrlich
Cancers 2024, 16(21), 3615; https://doi.org/10.3390/cancers16213615
Available online: https://www.mdpi.com/2072-6694/16/21/3615

3. “Colorectal Cancer Outcomes: A Comparative Review of Resource-Limited Settings in Low- and Middle-Income Countries and Rural America”
by Clare E. Jacobson, Calista M. Harbaugh, Kwabena Agbedinu and Gifty Kwakye
Cancers 2024, 16(19), 3302; https://doi.org/10.3390/cancers16193302
Available online: https://www.mdpi.com/2072-6694/16/19/3302

4. “Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome”
by Timothy T.A.F. Obergfell, Kim N. Nydegger, Philip Heesen, Georg Schelling, Beata Bode-Lesniewska, Gabriela Studer and Bruno Fuchs
Cancers 2024, 16(13), 2443; https://doi.org/10.3390/cancers16132443
Available online: https://www.mdpi.com/2072-6694/16/13/2443

5. “Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy”
by Calogero Cipolla, Vittorio Gebbia, Eleonora D’Agati, Martina Greco, Chiara Mesi, Giuseppa Scandurra and Maria Rosaria Valerio
Cancers 2024, 16(19), 3354; https://doi.org/10.3390/cancers16193354
Available online: https://www.mdpi.com/2072-6694/16/19/3354

6. “Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia”
by Nour Sabiha Naji, Mrudula Sathish and Theodoros Karantanos
Cancers 2024, 16(23), 3974; https://doi.org/10.3390/cancers16233974
Available online: https://www.mdpi.com/2072-6694/16/23/3974

7. “The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma”
by Linda Galasso, Lucia Cerrito, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini and Maria Assunta Zocco
Cancers 2024, 16(19), 3247; https://doi.org/10.3390/cancers16193247
Available online: https://www.mdpi.com/2072-6694/16/19/3247

8. “Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site”
by Karolina Dorobisz, Tadeusz Dorobisz and Katarzyna Pazdro-Zastawny
Cancers 2024, 16(19), 3416; https://doi.org/10.3390/cancers16193416
Available online: https://www.mdpi.com/2072-6694/16/19/3416

9. “Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study”
by Anne Ravix, Carole Bandiera, Evelina Cardoso, Adrian Lata-Pedreira, Haithem Chtioui, Laurent Arthur Decosterd, Anna Dorothea Wagner, Marie Paule Schneider, Chantal Csajka and Monia Guidi
Cancers 2024, 16(12), 2193; https://doi.org/10.3390/cancers16122193
Available online: https://www.mdpi.com/2072-6694/16/12/2193

10. “Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer”
by Marek Mazurek, Monika Szewc, Monika Z. Sitarz, Ewa Dudzińska and Robert Sitarz
Cancers 2024, 16(18), 3163; https://doi.org/10.3390/cancers16183163
Available online: https://www.mdpi.com/2072-6694/16/18/3163

11. “Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts”
by Michihisa Moriguchi, Seita Kataoka and Yoshito Itoh
Cancers 2024, 16(13), 2387; https://doi.org/10.3390/cancers16132387
Available online: https://www.mdpi.com/2072-6694/16/13/2387

12. “Incidence and Characteristics of Multiple Primary Cancers: A 20-Year Retrospective Study of a Single Cancer Center in Korea”
by Jin-Hee Kwon, Heyjin Kim, Jin Kyung Lee, Young Jun Hong, Hye Jin Kang and Yoon Jung Jang
Cancers 2024, 16(13), 2346; https://doi.org/10.3390/cancers16132346
Available online: https://www.mdpi.com/2072-6694/16/13/2346

13. “Surface Markers and Chemokines/Cytokines of Tumor-Associated Macrophages in Osteosarcoma and Other Carcinoma Microenviornments—Contradictions and Comparisons”
by Rikito Tatsuno, Yoshihiro Komohara, Cheng Pan, Tomonori Kawasaki, Atsushi Enomoto, Takahiro Jubashi, Hiroyuki Kono, Masanori Wako, Tomoyuki Ashizawa, Hirotaka Haro et al.
Cancers 2024, 16(16), 2801; https://doi.org/10.3390/cancers16162801
Available online: https://www.mdpi.com/2072-6694/16/16/2801

14. “Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico”
by Carlos Eduardo Aranda Flores, Bente Marie Falang, Laura Gómez-Laguna, Guillermo Gómez Gutiérrez, Jorge Miguel Ortiz León, Miguel Uribe, Omar Cruz and Sveinung Wergeland Sørbye
Cancers 2024, 16(13), 2485; https://doi.org/10.3390/cancers16132485
Available online: https://www.mdpi.com/2072-6694/16/13/2485

15. “Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate Cancer”
by Arrigo Cattabriga, Benedetta Renzetti, Francesco Galuppi, Laura Bartalena, Caterina Gaudiano, Stefano Brocchi, Alice Rossi, Riccardo Schiavina, Lorenzo Bianchi, Eugenio Brunocilla et al.
Cancers 2024, 16(14), 2531; https://doi.org/10.3390/cancers16142531
Available online: https://www.mdpi.com/2072-6694/16/14/2531

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Pathophysiology” Section, which are listed below:

1. “Differential Diagnosis of Pigmented Lesions in the Oral Mucosa: A Clinical Based Overview and Narrative Review”
by Silvio Abati, Giacomo Francesco Sandri, Leonardo Finotello and Elisabetta Polizzi
Cancers 2024, 16(13), 2487; https://doi.org/10.3390/cancers16132487
Available online: https://www.mdpi.com/2072-6694/16/13/2487

2. “The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management”
by Andrea Amaroli, Isabella Panfoli, Matteo Bozzo, Sara Ferrando, Simona Candiani and Silvia Ravera
Cancers 2024, 16(14), 2580; https://doi.org/10.3390/cancers16142580
Available online: https://www.mdpi.com/2072-6694/16/14/2580

3. “Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)”
by ErinMarie O. Kimbrough, Julian A. Marin-Acevedo, Leylah M. Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian and Yanyan Lou
Cancers 2024, 16(13), 2366; https://doi.org/10.3390/cancers16132366
Available online: https://www.mdpi.com/2072-6694/16/13/2366

4. “Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment”
by Nikolaos Vitorakis, Antonios N. Gargalionis, Kostas A. Papavassiliou, Christos Adamopoulos and Athanasios G. Papavassiliou
Cancers 2024, 16(16), 2876; https://doi.org/10.3390/cancers16162876
Available online: https://www.mdpi.com/2072-6694/16/16/2876

5. “Emerging Role of Hippo-YAP (Yes-Associated Protein)/TAZ (Transcriptional Coactivator with PDZ-Binding Motif) Pathway Dysregulation in Renal Cell Carcinoma Progression”
by Varsha Mondal, Paul J. Higgins and Rohan Samarakoon
Cancers 2024, 16(15), 2758; https://doi.org/10.3390/cancers16152758
Available online: https://www.mdpi.com/2072-6694/16/15/2758

6. “Efficacy of Cisplatin–CXCR4 Antagonist Combination Therapy in Oral Cancer”
by Saori Yoshida, Hotaka Kawai, Yamin Soe, Htoo Shwe Eain, Sho Sanou, Kiyofumi Takabatake, Yohei Takeshita, Miki Hisatomi, Hitoshi Nagatsuka, Junichi Asaumi et al.
Cancers 2024, 16(13), 2326; https://doi.org/10.3390/cancers16132326
Available online: https://www.mdpi.com/2072-6694/16/13/2326

7. “Lung Cancer Subtyping: A Short Review”
by Farzana Siddique, Mohamed Shehata, Mohammed Ghazal, Sohail Contractor and Ayman El-Baz
Cancers 2024, 16(15), 2643; https://doi.org/10.3390/cancers16152643
Available online: https://www.mdpi.com/2072-6694/16/15/2643

8. “Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia”
by Alessandro Costa, Carmelo Gurnari, Emilia Scalzulli, Laura Cicconi, Luca Guarnera, Ida Carmosino, Raffaella Cerretti, Maria Laura Bisegna, Saveria Capria, Clara Minotti et al.
Cancers 2024, 16(18), 3214; https://doi.org/10.3390/cancers16183214
Available online: https://www.mdpi.com/2072-6694/16/18/3214

9. “miRNAs Dysregulated in Human Papillomavirus-Associated Benign Prostatic Lesions and Prostate Cancer”
by Sandra Viridiana Salgado-Hernández, Lucero Martínez-Retamoza, Rodolfo Ocadiz-Delgado, Salvador Pérez-Mora, Gladys Edith Cedeño-Arboleda, María del Consuelo Gómez-García, Patricio Gariglio and David Guillermo Pérez-Ishiwara
Cancers 2025, 17(1), 26; https://doi.org/10.3390/cancers17010026
Available online: https://www.mdpi.com/2072-6694/17/1/26

10. “Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC”
by Vivi Bafiti, Eleni Thanou, Sotiris Ouzounis, Athanasios Kotsakis, Vasilis Georgoulias, Evi Lianidou, Theodora Katsila and Athina Markou
Cancers 2024, 16(22), 3729; https://doi.org/10.3390/cancers16223729
Available online: https://www.mdpi.com/2072-6694/16/22/3729

11. “Mutations Matter: Unravelling the Genetic Blueprint of Invasive Lobular Carcinoma for Progression Insights and Treatment Strategies”
by Athanasios Kontogiannis, Eleftheria Karaviti, Dimitra Karaviti, Sophocles Lanitis, Georgia Gomatou, Nikolaos K. Syrigos and Elias Kotteas
Cancers 2024, 16(22), 3826; https://doi.org/10.3390/cancers16223826
Available online: https://www.mdpi.com/2072-6694/16/22/3826

12. “Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors”
by Kristina Jansen, Lara Kornfeld, Maximilian Lennartz, Sebastian Dwertmann Rico, Simon Kind, Viktor Reiswich, Florian Viehweger, Ahmed Abdulwahab Bawahab, Christoph Fraune, Natalia Gorbokon et al.
Cancers 2024, 16(23), 4052; https://doi.org/10.3390/cancers16234052
Available online: https://www.mdpi.com/2072-6694/16/23/4052

13. “Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients”
by Ava Kwong, Cecilia Yuen Sze Ho, Chun-Hang Au and Edmond Shiu-Kwan Ma
Cancers 2024, 16(14), 2547; https://doi.org/10.3390/cancers16142547
Available online: https://www.mdpi.com/2072-6694/16/14/2547

14. “Targeting the Leloir Pathway with Galactose-Based Antimetabolites in Glioblastoma”
by Martyn A. Sharpe, Omkar B. Ijare, Sudhir Raghavan, Alexandra M. Baskin, Brianna N. Baskin and David S. Baskin
Cancers 2024, 16(20), 3510; https://doi.org/10.3390/cancers16203510
Available online: https://www.mdpi.com/2072-6694/16/20/3510

15. “Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas”
by Omar Elghawy, Miao Cao, Jason Xu, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Colin J. Thomas, Jordan S. Carter et al.
Cancers 2024, 16(19), 3430; https://doi.org/10.3390/cancers16193430
Available online: https://www.mdpi.com/2072-6694/16/19/3430

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

March is designated as Myeloma Awareness Month, with various global activities that highlight and increase awareness of myeloma for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of myeloma, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

1. “Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma”
by Omar Nadeem, Sikander Ailawadhi, Jack Khouri, Louis Williams, Donna Catamero, Kathryn Maples and Jesús Berdeja
Cancers 2024, 16(5), 1023; https://doi.org/10.3390/cancers16051023
Available online: https://www.mdpi.com/2072-6694/16/5/1023

2. “Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma”
by Paola Tacchetti, Simona Barbato, Katia Mancuso, Elena Zamagni and Michele Cavo
Cancers 2024, 16(13), 2337; https://doi.org/10.3390/cancers16132337
Available online: https://www.mdpi.com/2072-6694/16/13/2337

3. “Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation”
by Rebecca Sheridan, Kieran Brennan, Despina Bazou, Peter O’Gorman, David Matallanas and Margaret M. Mc Gee
Cancers 2024, 16(5), 1011; https://doi.org/10.3390/cancers16051011
Available online: https://www.mdpi.com/2072-6694/16/5/1011

4. “Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma”
by Basudev Chowdhury, Swati Garg, Wei Ni, Martin Sattler, Dana Sanchez, Chengcheng Meng, Taisei Akatsu, Richard Stone, William Forrester, Edmund Harrington et al.
Cancers 2024, 16(7), 1319; https://doi.org/10.3390/cancers16071319
Available online: https://www.mdpi.com/2072-6694/16/7/1319

5. “Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma”
by Maciej Dubaj, Karol Bigosiński, Aleksandra Dembowska, Radosław Mlak, Aneta Szudy-Szczyrek, Teresa Małecka-Massalska and Iwona Homa-Mlak
Cancers 2024, 16(5), 1033; https://doi.org/10.3390/cancers16051033
Available online: https://www.mdpi.com/2072-6694/16/5/1033

6. “Functional Investigation of IGF1R Mutations in Multiple Myeloma”
by Sofia Catalina Heredia-Guerrero, Marietheres Evers, Sarah Keppler, Marlene Schwarzfischer, Viktoria Fuhr, Hilka Rauert-Wunderlich, Anne Krügl, Theodora Nedeva, Tina Grieb, Julia Pickert
Cancers 2024, 16(11), 2139; https://doi.org/10.3390/cancers16112139
Available online: https://www.mdpi.com/2072-6694/16/11/2139

7. “Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells’ Escape from the Bone Marrow Microenvironment”
by Stefaan W. Verbruggen, Ciara L. Freeman and Fiona E. Freeman
Cancers 2024, 16(5), 889; https://doi.org/10.3390/cancers16050889
Available online: https://www.mdpi.com/2072-6694/16/5/889

8. “The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management”
by Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia and Massimo Offidani
Cancers 2024, 16(12), 2263; https://doi.org/10.3390/cancers16122263
Available online: https://www.mdpi.com/2072-6694/16/12/2263

9. “Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation”
by Lixin Gong, Lugui Qiu and Mu Hao
Cancers 2024, 16(3), 498; https://doi.org/10.3390/cancers16030498
Available online: https://www.mdpi.com/2072-6694/16/3/498

10. “Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery”
by Julian Mehl, Dilara Akhoundova, Ulrike Bacher, Barbara Jeker, Gaëlle Rhyner Agocs, Axel Ruefer, Susanne Soltermann, Martin Soekler, Annette Winkler, Michael Daskalakis et al.
Cancers 2024, 16(10), 1854; https://doi.org/10.3390/cancers16101854
Available online: https://www.mdpi.com/2072-6694/16/10/1854

11. “Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients”
by Omar S. Al-Odat, Emily Nelson, Tulin Budak-Alpdogan, Subash C. Jonnalagadda, Dhimant Desai and Manoj K. Pandey
Cancers 2024, 16(13), 2381; https://doi.org/10.3390/cancers16132381
Available online: https://www.mdpi.com/2072-6694/16/13/2381

12. “A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation”
by Wancheng Guo, Christopher Strouse, David Mery, Eric R. Siegel, Manit N. Munshi, Timothy Cody Ashby, Yan Cheng, Fumou Sun, Visanu Wanchai, Zijun Zhang et al.
Cancers 2024, 16(6), 1116; https://doi.org/10.3390/cancers16061116
Available online: https://www.mdpi.com/2072-6694/16/6/1116

13. “Effects on the Physical Functioning of Two Exercise Interventions in Patients with Multiple Myeloma: A Pilot Feasibility Study”
by Jens Hillengass, Michaela Hillengass, Janine M. Joseph, Kristopher Attwood, Rikki Cannioto, Hillary Jacobson, Carolyn Miller, Bryan Wittmeyer and Kirsten Moysich
Cancers 2024, 16(9), 1774; https://doi.org/10.3390/cancers16091774
Available online: https://www.mdpi.com/2072-6694/16/9/1774

14. “IL1B Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients”
by Marcin Mazurek, Aneta Szudy-Szczyrek, Iwona Homa-Mlak, Marek Hus, Teresa Małecka-Massalska and Radosław Mlak
Cancers 2024, 16(7), 1263; https://doi.org/10.3390/cancers16071263
Available online: https://www.mdpi.com/2072-6694/16/7/1263

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Causes, Screening and Diagnosis” Section, which are listed below:

1. “Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO)”
by Stefano Restaino, Giulia Pellecchia, Martina Arcieri, Giorgio Bogani, Cristina Taliento, Pantaleo Greco, Lorenza Driul, Vito Chiantera, Alfredo Ercoli, Francesco Fanfani et al.
Cancers 2024, 16(14), 2541; https://doi.org/10.3390/cancers16142541
Available online: https://www.mdpi.com/2072-6694/16/14/2541

2. “Non-Invasive Markers for the Detection of Gastric Precancerous Conditions”
by Marcin Romańczyk, Malgorzata Osmola, Alexander Link, Amaury Druet, Caroline Hémont, Jerome Martin, Nicolas Chapelle and Tamara Matysiak-Budnik
Cancers 2024, 16(12), 2254; https://doi.org/10.3390/cancers16122254
Available online: https://www.mdpi.com/2072-6694/16/12/2254

3. “Post-Progression Analysis of EGFR-Mutant NSCLC Following Osimertinib Therapy in Real-World Settings”
by Ilaria Attili, Carla Corvaja, Gianluca Spitaleri, Pamela Trillo Aliaga, Ester Del Signore, Antonio Passaro and Filippo de Marinis
Cancers 2024, 16(14), 2589; https://doi.org/10.3390/cancers16142589
Available online: https://www.mdpi.com/2072-6694/16/14/2589

4. “The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review”
by Radwa Hablase, Ioannis Kyrou, Harpal Randeva, Emmanouil Karteris and Jayanta Chatterjee
Cancers 2024, 16(11), 2160; https://doi.org/10.3390/cancers16112160
Available online: https://www.mdpi.com/2072-6694/16/11/2160

5. “Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification”
by Anna Russo, Vittorio Patanè, Federico Gagliardi, Fabrizio Urraro, Andrea Ronchi, Paola Vitiello, Antonello Sica, Giuseppe Argenziano, Valerio Nardone and Alfonso Reginelli
Cancers 2024, 16(13), 2456; https://doi.org/10.3390/cancers16132456
Available online: https://www.mdpi.com/2072-6694/16/13/2456

6. “Enhancing Early Lung Cancer Diagnosis: Predicting Lung Nodule Progression in Follow-Up Low-Dose CT Scan with Deep Generative Model”
by Yifan Wang, Chuan Zhou, Lei Ying, Heang-Ping Chan, Elizabeth Lee, Aamer Chughtai, Lubomir M. Hadjiiski and Ella A. Kazerooni
Cancers 2024, 16(12), 2229; https://doi.org/10.3390/cancers16122229
Available online: https://www.mdpi.com/2072-6694/16/12/2229

7. “Revisiting Querleu–Morrow Radical Hysterectomy: How to Apply the Anatomy of Parametrium and Pelvic Autonomic Nerves to Cervical Cancer Surgery?”
by Stoyan Kostov, Yavor Kornovski, Rafał Watrowski, Angel Yordanov, Stanislav Slavchev, Yonka Ivanova, Hakan Yalcin, Ivan Ivanov and Ilker Selcuk
Cancers 2024, 16(15), 2729; https://doi.org/10.3390/cancers16152729
Available online: https://www.mdpi.com/2072-6694/16/15/2729

8. “Amplified Cell Cycle Genes Identified in High-Grade Serous Ovarian Cancer”
by Karthik Balakrishnan, Yuanhong Chen and Jixin Dong
Cancers 2024, 16(16), 2783; https://doi.org/10.3390/cancers16162783
Available online: https://www.mdpi.com/2072-6694/16/16/2783

9. “Prevalence of Sarcopenia Determined by Computed Tomography in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Observational Studies”
by Antonio Jesús Láinez Ramos-Bossini, Antonio Gámez Martínez, David Luengo Gómez, Francisco Valverde-López, Consolación Melguizo and José Prados
Cancers 2024, 16(19), 3356; https://doi.org/10.3390/cancers16193356
Available online: https://www.mdpi.com/2072-6694/16/19/3356

10. “Prognostic Relevance of Preoperative Immune, Inflammatory, and Nutritional Biomarkers in Patients Undergoing Gastrectomy for Resectable Gastric Adenocarcinoma: An Observational Multicentre Study”
by Jaume Tur-Martínez, Joaquín Rodríguez-Santiago, Javier Osorio, Mònica Miró, Concepción Yarnoz, Mariona Jofra, Georgina Ferret, Helena Salvador-Roses, Sonia Fernández-Ananín, Arantxa Clavell et al.
Cancers 2024, 16(12), 2188; https://doi.org/10.3390/cancers16122188
Available online: https://www.mdpi.com/2072-6694/16/12/2188

11. “Wearable Devices in Colorectal Surgery: A Scoping Review”
by Konstantinos Kavallieros, Lampros Karakozis, Romilly Hayward, Emmanuel Giannas, Lucio Selvaggi and Christos Kontovounisios
Cancers 2024, 16(13), 2303; https://doi.org/10.3390/cancers16132303
Available online: https://www.mdpi.com/2072-6694/16/13/2303

12. “Locally Advanced Cervical Cancer: Neoadjuvant Treatment versus Standard Radio-Chemotherapy—An Updated Meta-Analysis”
by Carlo Ronsini, Maria Cristina Solazzo, Eleonora Braca, Giada Andreoli, Maria Giovanna Vastarella, Stefano Cianci, Vito Andrea Capozzi, Marco Torella, Luigi Cobellis and Pasquale De Franciscis
Cancers 2024, 16(14), 2542; https://doi.org/10.3390/cancers16142542
Available online: https://www.mdpi.com/2072-6694/16/14/2542

13. “WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver ”
by Roxana Șirli, Alina Popescu, Christian Jenssen, Kathleen Möller, Adrian Lim, Yi Dong, Ioan Sporea, Dieter Nürnberg, Marieke Petry and Christoph F. Dietrich
Cancers 2024, 16(16), 2908; https://doi.org/10.3390/cancers16162908
Available online: https://www.mdpi.com/2072-6694/16/16/2908

14. “The Role of Radiomics in the Prediction of Clinically Significant Prostate Cancer in the PI-RADS v2 and v2.1 Era: A Systematic Review”
by Andreu Antolin, Nuria Roson, Richard Mast, Javier Arce, Ramon Almodovar, Roger Cortada, Almudena Maceda, Manuel Escobar, Enrique Trilla and Juan Morote
Cancers 2024, 16(17), 2951; https://doi.org/10.3390/cancers16172951
Available online: https://www.mdpi.com/2072-6694/16/17/2951

15. “Leucocyte Telomere Length and Lung Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies”
by Roberto Fabiani, Manuela Chiavarini, Patrizia Rosignoli and Irene Giacchetta
Cancers 2024, 16(18), 3218; https://doi.org/10.3390/cancers16183218
Available online: https://www.mdpi.com/2072-6694/16/18/3218

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office